Inhibikase Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts that cover Inhibikase Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $5.00, which forecasts a 157.07% increase in the stock price over the next year. The lowest target is $3.00 and the highest is $8.00.

Price Target: $5.00 (+157.07%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$3.00	$5.00	$4.00	$8.00
Change	+54.24%	+157.07%	+105.66%	+311.31%

* Price targets were last updated on Mar 4, 2026.

Analyst Ratings

The average analyst rating for Inhibikase Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	3	3	4	4	4
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	5	5	6	6	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Aydin Huseynov Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Initiates $4	Strong Buy	Initiates	$4	+105.66%	Mar 4, 2026
Jason Zemansky B of A Securities	B of A Securities	Strong Buy Initiates $6	Strong Buy	Initiates	$6	+208.48%	Jan 21, 2026
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+311.31%	Dec 26, 2025
Ilya Zubkov Freedom Broker	Freedom Broker	Strong Buy Initiates $3	Strong Buy	Initiates	$3	+54.24%	Dec 17, 2025
Olivia Brayer Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates $4	Buy	Initiates	$4	+105.66%	Dec 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

288.57K

Revenue Next Year

288.57K

from 288.57K

EPS This Year

-0.55

from -0.49

EPS Next Year

-0.56

from -0.55

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	3.10M	123.44K	260.50K	-	-	288.57K	288.57K
Revenue Growth	343.92%	-96.02%	111.04%	-	-	-	-
EPS	-4.87	-4.28	-3.16	-1.16	-0.49	-0.55	-0.56
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	2.1M	2.1M
Avg	288,567	288,567
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	627.7%
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.39	-0.37
Avg	-0.55	-0.56
Low	-0.98	-0.98

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.